Increasing support to R&D from pharmaceuticals and biotech firms and low cost of clinical trials in developed economies are key factors driving market growth
VANCOUVER, BC, CANADA, April 25, 2023 /EINPresswire.com/ — The global clinical biomarkers market is expected to reach a market size of USD 38.79 Billion by 2027 and register a robust double-digit CAGR over the forecast period, according to the latest report by Emergen Research. Rising need for customized medication worldwide, increasing investment in R&D initiatives to develop more efficient biomarkers, and rising prevalence of cardiovascular diseases, disorders, and cancers are key factors expected to drive growth of the global biomarker market over the forecast period.
Clinical Biomarkers Market Analysis Report, Size, Trends, Forecast, Research, prepaidbill login Applications, Types and Outlook 2027
